Literature DB >> 28404854

Autologous Stem Cell Transplantation Disrupts Adaptive Immune Responses during Rebound Simian/Human Immunodeficiency Virus Viremia.

Daniel B Reeves1, Christopher W Peterson2,3, Hans-Peter Kiem2,3,4, Joshua T Schiffer5,2,3.   

Abstract

Primary HIV-1 infection induces a virus-specific adaptive/cytolytic immune response that impacts the plasma viral load set point and the rate of progression to AIDS. Combination antiretroviral therapy (cART) suppresses plasma viremia to undetectable levels that rebound upon cART treatment interruption. Following cART withdrawal, the memory component of the virus-specific adaptive immune response may improve viral control compared to primary infection. Here, using primary infection and treatment interruption data from macaques infected with simian/human immunodeficiency virus (SHIV), we observe a lower peak viral load but an unchanged viral set point during viral rebound. The addition of an autologous stem cell transplant before cART withdrawal alters viral dynamics: we found a higher rebound set point but similar peak viral loads compared to the primary infection. Mathematical modeling of the data that accounts for fundamental immune parameters achieves excellent fit to heterogeneous viral loads. Analysis of model output suggests that the rapid memory immune response following treatment interruption does not ultimately lead to better viral containment. Transplantation decreases the durability of the adaptive immune response following cART withdrawal and viral rebound. Our model's results highlight the impact of the endogenous adaptive immune response during primary SHIV infection. Moreover, because we capture adaptive immune memory and the impact of transplantation, this model will provide insight into further studies of cure strategies inspired by the Berlin patient.IMPORTANCE HIV patients who interrupt combination antiretroviral therapy (cART) eventually experience viral rebound, the return of viral loads to pretreatment levels. However, the "Berlin patient" remained free of HIV rebound over a decade after stopping cART. His cure is attributed to leukemia treatment that included an HIV-resistant stem cell transplant. Inspired by this case, we studied the impact of stem cell transplantation in a macaque simian/HIV (SHIV) system. Using a mechanistic mathematical model, we found that while primary infection generates an adaptive immune memory response, stem cell transplantation disrupts this learned immunity. The results have implications for HIV cure regimens based on stem cell transplantation.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  Berlin patient; SHIV; hematopoietic stem cell transplant; human immunodeficiency virus; macaque model; mathematical modeling

Mesh:

Substances:

Year:  2017        PMID: 28404854      PMCID: PMC5469274          DOI: 10.1128/JVI.00095-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

1.  Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus.

Authors:  P Borrow; H Lewicki; X Wei; M S Horwitz; N Peffer; H Meyers; J A Nelson; J E Gairin; B H Hahn; M B Oldstone; G M Shaw
Journal:  Nat Med       Date:  1997-02       Impact factor: 53.440

2.  Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.

Authors:  J E Schmitz; M J Kuroda; S Santra; V G Sasseville; M A Simon; M A Lifton; P Racz; K Tenner-Racz; M Dalesandro; B J Scallon; J Ghrayeb; M A Forman; D C Montefiori; E P Rieber; N L Letvin; K A Reimann
Journal:  Science       Date:  1999-02-05       Impact factor: 47.728

3.  HIV and Stem Cell Transplantation.

Authors:  Ignacio A Echenique; George E Nelson; Valentina Stosor; Christine M Durand
Journal:  Curr Infect Dis Rep       Date:  2014-09       Impact factor: 3.725

4.  Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection.

Authors:  Gilad Doitsh; Nicole L K Galloway; Xin Geng; Zhiyuan Yang; Kathryn M Monroe; Orlando Zepeda; Peter W Hunt; Hiroyu Hatano; Stefanie Sowinski; Isa Muñoz-Arias; Warner C Greene
Journal:  Nature       Date:  2014-01-23       Impact factor: 49.962

5.  Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis.

Authors:  B Ramratnam; S Bonhoeffer; J Binley; A Hurley; L Zhang; J E Mittler; M Markowitz; J P Moore; A S Perelson; D D Ho
Journal:  Lancet       Date:  1999-11-20       Impact factor: 79.321

6.  Turnover rates of B cells, T cells, and NK cells in simian immunodeficiency virus-infected and uninfected rhesus macaques.

Authors:  Rob J De Boer; Hiroshi Mohri; David D Ho; Alan S Perelson
Journal:  J Immunol       Date:  2003-03-01       Impact factor: 5.422

7.  Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.

Authors:  R A Koup; J T Safrit; Y Cao; C A Andrews; G McLeod; W Borkowsky; C Farthing; D D Ho
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

8.  Human immunodeficiency virus type 1-specific CD8+ T-cell responses during primary infection are major determinants of the viral set point and loss of CD4+ T cells.

Authors:  Hendrik Streeck; Jonathan S Jolin; Ying Qi; Bader Yassine-Diab; Randall C Johnson; Douglas S Kwon; Marylyn M Addo; Chanson Brumme; Jean-Pierre Routy; Susan Little; Heiko K Jessen; Anthony D Kelleher; Frederick M Hecht; Rafick-Pierre Sekaly; Eric S Rosenberg; Bruce D Walker; Mary Carrington; Marcus Altfeld
Journal:  J Virol       Date:  2009-05-20       Impact factor: 5.103

9.  Determination of virus burst size in vivo using a single-cycle SIV in rhesus macaques.

Authors:  Hannah Yuan Chen; Michele Di Mascio; Alan S Perelson; David D Ho; Linqi Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-19       Impact factor: 11.205

10.  Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection.

Authors:  P Borrow; H Lewicki; B H Hahn; G M Shaw; M B Oldstone
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

View more
  11 in total

1.  Novel full-length major histocompatibility complex class I allele discovery and haplotype definition in pig-tailed macaques.

Authors:  Matthew R Semler; Roger W Wiseman; Julie A Karl; Michael E Graham; Samantha M Gieger; David H O'Connor
Journal:  Immunogenetics       Date:  2017-11-13       Impact factor: 2.846

2.  Thresholds for post-rebound SHIV control after CCR5 gene-edited autologous hematopoietic cell transplantation.

Authors:  E Fabian Cardozo-Ojeda; Elizabeth R Duke; Christopher W Peterson; Daniel B Reeves; Bryan T Mayer; Hans-Peter Kiem; Joshua T Schiffer
Journal:  Elife       Date:  2021-01-12       Impact factor: 8.713

3.  Stem cell-derived CAR T cells traffic to HIV reservoirs in macaques.

Authors:  Isaac M Barber-Axthelm; Valerie Barber-Axthelm; Kai Yin Sze; Anjie Zhen; Gajendra W Suryawanshi; Irvin Sy Chen; Jerome A Zack; Scott G Kitchen; Hans-Peter Kiem; Christopher W Peterson
Journal:  JCI Insight       Date:  2021-01-11

4.  Estimation of the in vivo neutralization potency of eCD4Ig and conditions for AAV-mediated production for SHIV long-term remission.

Authors:  Ashish Goyal; Matthew Gardner; Bryan T Mayer; Keith R Jerome; Michael Farzan; Joshua T Schiffer; E Fabian Cardozo-Ojeda
Journal:  Sci Adv       Date:  2022-01-12       Impact factor: 14.136

5.  Human resident memory T cells exit the skin and mediate systemic Th2-driven inflammation.

Authors:  Johanna Strobl; Laura Marie Gail; Lisa Kleissl; Ram Vinay Pandey; Valerie Smejkal; Julian Huber; Viktoria Puxkandl; Luisa Unterluggauer; Ruth Dingelmaier-Hovorka; Denise Atzmüller; Thomas Krausgruber; Christoph Bock; Philipp Wohlfarth; Werner Rabitsch; Georg Stary
Journal:  J Exp Med       Date:  2021-10-13       Impact factor: 14.307

6.  HIV Proviral Burden, Genetic Diversity, and Dynamics in Viremic Controllers Who Subsequently Initiated Suppressive Antiretroviral Therapy.

Authors:  F Harrison Omondi; Hanwei Sudderuddin; Aniqa Shahid; Natalie N Kinloch; Bradley R Jones; Rachel L Miller; Olivia Tsai; Daniel MacMillan; Alicja Trocha; Mark A Brockman; Chanson J Brumme; Jeffrey B Joy; Richard Liang; Bruce D Walker; Zabrina L Brumme
Journal:  mBio       Date:  2021-11-16       Impact factor: 7.867

7.  Proviral Turnover During Untreated HIV Infection Is Dynamic and Variable Between Hosts, Impacting Reservoir Composition on ART.

Authors:  Kelsie Brooks; F Harrison Omondi; Richard H Liang; Hanwei Sudderuddin; Bradley R Jones; Jeffrey B Joy; Chanson J Brumme; Eric Hunter; Zabrina L Brumme
Journal:  Front Microbiol       Date:  2021-08-19       Impact factor: 5.640

8.  Timing HIV infection with a simple and accurate population viral dynamics model.

Authors:  Daniel B Reeves; Morgane Rolland; Bethany L Dearlove; Yifan Li; Merlin L Robb; Joshua T Schiffer; Peter Gilbert; E Fabian Cardozo-Ojeda; Bryan T Mayer
Journal:  J R Soc Interface       Date:  2021-06-30       Impact factor: 4.293

9.  Dynamics of HIV DNA reservoir seeding in a cohort of superinfected Kenyan women.

Authors:  Mark D Pankau; Daniel B Reeves; Elias Harkins; Keshet Ronen; Walter Jaoko; Kishor Mandaliya; Susan M Graham; R Scott McClelland; Frederick A Matsen Iv; Joshua T Schiffer; Julie Overbaugh; Dara A Lehman
Journal:  PLoS Pathog       Date:  2020-02-05       Impact factor: 7.464

10.  Mathematical modeling to reveal breakthrough mechanisms in the HIV Antibody Mediated Prevention (AMP) trials.

Authors:  Daniel B Reeves; Yunda Huang; Elizabeth R Duke; Bryan T Mayer; E Fabian Cardozo-Ojeda; Florencia A Boshier; David A Swan; Morgane Rolland; Merlin L Robb; John R Mascola; Myron S Cohen; Lawrence Corey; Peter B Gilbert; Joshua T Schiffer
Journal:  PLoS Comput Biol       Date:  2020-02-21       Impact factor: 4.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.